Targeted therapies in breast cancer: challenging questions from oncology nurses.
Becze
Elisa
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D016503:Drug Delivery Systems / Q000009:adverse effects / Q000379:methods* / Q000451:nursing; D016903:Drug Monitoring; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects / Q000502:physiology; D006801:Humans; D000077341:Lapatinib; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration*; D011799:Quinazolines / Q000627:therapeutic use; D000068878:Trastuzumab; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects / Q000502:physiology